dc.contributorStony Brook University Medical Center
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:24:42Z
dc.date.accessioned2022-10-05T18:21:19Z
dc.date.available2014-05-27T11:24:42Z
dc.date.available2022-10-05T18:21:19Z
dc.date.created2014-05-27T11:24:42Z
dc.date.issued2010-06-01
dc.identifierJornal Vascular Brasileiro, v. 9, n. 2, p. 72-75, 2010.
dc.identifier1677-5449
dc.identifierhttp://hdl.handle.net/11449/71706
dc.identifier10.1590/S1677-54492010000200010
dc.identifierS1677-54492010000200010
dc.identifier2-s2.0-77958122307
dc.identifier2-s2.0-77958122307.pdf
dc.identifier9609324832591382
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3920846
dc.description.abstractRecurrent venous thromboembolism is a significant problem leading to increased morbidity and mortality. It has a high impact on patients' quality of life and imposes a great financial burden on society. Cumulative recurrence has been reported as 40% at 10 years, while the chance of developing postthrombotic signs and symptoms in the lower extremities almost quadruples when ipsilateral. There is also a higher chance of developing pulmonary hypertension. Important factors for recurrence are unprovoked episodes of deep vein thrombosis, malignancy and older age. The evidence for other factors is controversial. Accurate diagnosis and treatment tailored to the patients' history, thrombotic events and risk factors are necessary to optimize management and prevent recurrence.
dc.languagepor
dc.relationJornal Vascular Brasileiro
dc.relation0,136
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectAnticoagulation
dc.subjectPostthrombotic syndrome
dc.subjectPulmonary hypertension
dc.subjectRecurrent venous thromboembolism
dc.subjectanticoagulant agent
dc.subjectantivitamin K
dc.subjectheparin
dc.subjectanticoagulant therapy
dc.subjectblood clot lysis
dc.subjectclinical classification
dc.subjectcompression garment
dc.subjectcomputer assisted tomography
dc.subjectdeep vein thrombosis
dc.subjectdiagnostic accuracy
dc.subjectdiagnostic imaging
dc.subjectdisease duration
dc.subjectdisease severity
dc.subjectechography
dc.subjectfollow up
dc.subjecthigh risk patient
dc.subjecthuman
dc.subjectlung embolism
dc.subjectmedical history
dc.subjectmortality
dc.subjectnuclear magnetic resonance imaging
dc.subjectpatient attitude
dc.subjectpostthrombosis syndrome
dc.subjectpulmonary hypertension
dc.subjectquality of life
dc.subjectrecurrent disease
dc.subjectrisk assessment
dc.subjectrisk factor
dc.subjectrisk reduction
dc.subjectsensitivity and specificity
dc.subjectsurvival rate
dc.subjectsymptomatology
dc.subjectthrombosis prevention
dc.subjecttreatment duration
dc.subjecttreatment indication
dc.titleSignificância clínica de tromboembolismo venoso recorrente
dc.typeArtigo


Este ítem pertenece a la siguiente institución